PharmaTher Provides Update on Product Pipeline and Expected Milestones for 2022
Focused on becoming a leader in the development and commercialization of specialty ketamine prescription-based products Expected milestones for 2022 include...
News
Aurora Spine Corporation Announces Newly Published Paper on Need for a Bone Mineral Density-Matched Interbody Cage
CARLSBAD, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),...
ADMA Biologics Adopts Limited Duration Stockholder Rights Plan
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 21, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial...
LianBio Announces Infigratinib Approved Under Special Named Patient Program for the Treatment of Cholangiocarcinoma in the Pilot Zone of Hainan Province in China
SHANGHAI, China and PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing...
XORTX Therapeutics Announces Filing of Provision Patent for Polycystic Kidney Disease
• Increased Xanthine Oxidase Expression in ADPKD Kidneys •CALGARY, Alberta, Dec. 21, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX"...
BioRestorative Therapies CEO Interviewing Live on the James Hicks NewMedia Show
MELVILLE, N.Y., Dec. 21, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company...
Samsung Bioepis Releases First Annual Sustainability Report
Outlines the company’s Environment, Social and Governance (ESG) performance and commitment to becoming a socially responsible and sustainable companyAppoints dedicated...
Helsinn Group Announces European Medicines Agency’s (EMA) Acceptance for review of the Marketing Authorization Application (MAA) for Infigratinib for Patients with Cholangiocarcinoma with Fibroblast Growth Factor Receptor 2 Fusions or Rearr
Helsinn Group Announces European Medicines Agency’s (EMA) Acceptance for review of the Marketing Authorization Application (MAA) for Infigratinib for Patients...
AirPhysio OPEP For Asthma – Airway Cleaning Natural Symptom Management Relaunch
Life Wellness Healthcare, leading respiratory specialist suppliers, have announced a relaunch of the top-selling all-natural AirPhysio breathing device for individuals...
Mainz BioMed Appoints Karen Richards as Vice President, Regulatory Affairs to Lead US FDA Approval Process
BERKELEY, Calif. and MAINZ, Germany, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),...
Indigo Diabetes Business Update
PRESS RELEASE Indigo Diabetes Business Update BELGIUM – Ghent, December 21, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’),...
Immunicum Publishes Year-End Letter by CEO and Announces Upcoming Shareholder Event to Present Pipeline Outlook
Press Release Stockholm, Sweden, December 21, 2021 Immunicum Publishes Year-End Letter by CEO and Announces Upcoming Shareholder Event to Present...
Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba® (isavuconazole) in China
Chinese National Medical Products Administration (NMPA) granted Drug Approval License for Cresemba in China to Basilea’s license partner PfizerAd hoc...
Acacia Pharma Issues Ordinary Shares to its Employee Benefit Trust
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. Publication in application of Article 15 of the Law of 2 May 2007 (the Transparency...
IBA and New Mexico Cancer Center sign contract to install a Proteus®ONE proton therapy solution in Albuquerque, USA
Louvain-La-Neuve, Belgium, December 21, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader...
EssilorLuxottica : Final results of EssilorLuxottica’s public offer for GrandVision shares
Final results of EssilorLuxottica’s public offerfor GrandVision shares Following the Post-Acceptance Period that ended on December 20, the Offeror will...
Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics
Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics Adds promising pipeline of T-cell engagers and cytokine...
Aquestive Therapeutics Receives Notification from FDA that It Will Not Be Ready to Take Action by December 23, 2021 for the Company’s NDA for Libervant™ (diazepam) Buccal Film
WARREN, N.J., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and...
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWTOWN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech...
Lobe Sciences Announces Publication of PCT Patent Application for Its Combination Therapy for mTBI and PTSD
"Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with...
